Since Sirt2−/− HCCs were more differentiated and had fewer proliferative and immunological markers than Sirt2+/+ HCCs, a loss of Sirt2 resulted in a lesser HCC tumor grade 36 days post-c-MYC induction. The gene discussed is SIRT2; the disease is hepatocellular carcinoma.